Home / Media Center / News

Search

TRINITY LIFE SCIENCES LAUNCHES BRAND INSIGHTS AI

New Chat-based AI Interface Allows Life Sciences Executives to Unlock the Collective Power of All Their Brand Research Waltham, MA, February 28, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched Brand Insights AI to develop, share and refine insights across the full breadth of biopharmaceutical brand research. Designed by experts with deep technical knowledge and expertise in the nuances of life sciences research, it allows insights and analytics teams to answer brand questions…

Read Now

TRINITY LIFE SCIENCES EVALUATES COMMERCIAL PERFORMANCE OVER 3 YEARS OF 58 NOVEL DRUGS APPROVED IN 2020

“Trinity Annual Drug Index” White Paper Now Available An Upcoming Webinar Entitled “Learn From the Past – Launch Better Tomorrow” Will Review Findings Waltham, MA, February 13, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of its Trinity Annual Drug Index white paper, an evaluation of the commercial performances over three years of 58 novel drugs approved in 2020. An upcoming webinar Learn From the Past – Launch Better Tomorrow will help…

Read Now

CHINA’S 2022 NRDL UPDATE DEMONSTRATES PROMISING PRICING AND ACCESS OPPORTUNITIES FOR INNOVATIVE DRUGS WITH SIGNIFICANT CLINICAL BENEFIT

New White Paper “2022 NRDL Pricing Implementation and Access Outcomes in China” Available Now from Trinity Life Sciences Waltham, MA, December 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that China’s 2022 National Reimbursement Drug List (NRDL) demonstrates promising pricing and access opportunities for innovative drugs with significant clinical benefit. The new white paper “2022 NRDL Pricing Implementation and Access Outcomes in China” provides an in-depth analysis and key takeaways of the update.…

Read Now

TRINITY LIFE SCIENCES INSTITUTES A FORMAL CELL AND GENE THERAPY CENTER OF EXCELLENCE

COE Provides Deep Strategic Expertise and Analytical Capabilities to Support Cell and Gene Therapy Organizations Across the Value Chain New White Paper “Empowering Cancer Immunotherapy: Unleashing the Potential of NK Cell Therapies in Oncology” Delivers Overarching Assessment of the Natural Killer Cell Therapy Space Waltham, MA, December 18, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces a Cell & Gene Therapy (C&GT) Center of Excellence (COE) that supports life sciences companies in successfully commercializing…

Read Now

NEW ADVISORY BRIEF REVEALS WHAT LIFE SCIENCES COMPANIES NEED TO KNOW NOW TO BE PREPARED FOR 2024

Waltham, MA, December 13, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know Now To Be Prepared for 2024” based on highlights presented at the TGaS Advisors’ 2023 Fall Client Summit. The TGaS 2023 Fall Client Summit included 16 function-specific sessions in the areas of commercial operations, market access and medical affairs. The sessions were held virtually in October and November with over 500…

Read Now

PFIZER’S NURTEC RECEIVES TOP RANKING IN 2023 TGAS DIGITAL MARKETING COMPETENCY REPORT

Waltham, MA, November 29, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates the brands across five categories and more than 100 characteristics to understand each one’s digital marketing presence and establish a brand digital competency ranking. Brands that topped the 2023 Digital Marketing Competency Report’s list include: Pfizer’s Nurtec Idorsia’s Quviviq…

Read Now

TRINITY LIFE SCIENCES MAPS OUT INVESTMENT STRATEGIES AND TACTICS TO CALIBRATE A PATIENT-CENTRIC APPROACH IN RARE DISEASE

New Advisory Brief Discusses Four Pillars to Focus Resource Allocation, Improve Patient Care and Provide Differentiated Patient Partnership Waltham, MA, November 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out investment strategies and tactics to calibrate a patient-centric approach in rare disease in its new advisory brief. The brief outlines four pillars that focus resource allocation, improve patient care and provide differentiated patient partnership. Within the nuances of each disease, companies must effectively…

Read Now

TRINITY LIFE SCIENCES NAMES FIRST CHIEF TECHNOLOGY OFFICER

Rajeev Rangachari Plans to Bolster a Culture of Innovation Waltham, MA, October 23, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced the appointment of Rajeev Rangachari to serve as the Company’s first-ever Chief Technology Officer (CTO). Mr. Rangachari brings significant experience in building flexible, scalable solutions for life sciences organizations to Trinity. As CTO, Mr. Rangachari will infuse technology into every aspect of Trinity’s offerings and workflow, accelerating business processes with technology assets.…

Read Now

TRINITY LIFE SCIENCES USES NEW “TETHERED” APPROACH TO INTEGRATE HCP-LEVEL REAL-WORLD DATA AND IMPROVE BRAND SHARE ESTIMATES

New White Paper Maps Out Method that Significantly Improves Prediction of Future Prescribing Behavior in Demand Studies Waltham, MA, October 11, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces the first method that incorporates Healthcare Professionals (HCP)-specific real-world behaviors to improve share calibration for forecasting.  The method, called “tethering,” uses real-world prescribing behaviors to calibrate share estimates from primary market research (PMR) by connecting them to the current market scenario. This real-world calibration at…

Read Now

NEW WHITE PAPER REVEALS THE GOOD, THE BAD AND THE UGLY ON THE JOURNEY TO FULL GLOBALIZATION FOR PHARMA COMMERCIAL OPERATIONS TEAMS

Waltham, MA, October 9, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ white paper “The Globalization Marathon: Is Pharma Commercial Operations Moving to a Full Global Operating Model?” The white paper is based on primary research conducted by TGaS with a subset of its ~100 member companies’ Commercial Operations leaders representing large, mid-size and emerging pharmaceutical companies operating in global markets. The research found that most organizations are not…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.